Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and clinical effects of escalating doses of clonidine in ICU patients
2015-001699-23Phase 3Completed
- Sponsor
- Deventer Ziekenhuis
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clonidine in delirium, sponsored by Deventer Ziekenhuis. Primary endpoint: Cessation of the need for sedative therapy. Started Nov 2015; status: completed.
02
Drugs
clonidine
03
Conditions
delirium
Beyond the preview
Go deeper on 2015-001699-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001699-23.